AzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis Therapeutics Development Network Sites

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing